These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 17941342

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism.
    Lehtovirta M, Soininen H, Helisalmi S, Mannermaa A, Helkala EL, Hartikainen P, Hänninen T, Ryynänen M, Riekkinen PJ.
    Neurology; 1996 Feb; 46(2):413-9. PubMed ID: 8614504
    [Abstract] [Full Text] [Related]

  • 3. Apolipoprotein E epsilon4 and age at onset of sporadic and familial Alzheimer disease in Caribbean Hispanics.
    Olarte L, Schupf N, Lee JH, Tang MX, Santana V, Williamson J, Maramreddy P, Tycko B, Mayeux R.
    Arch Neurol; 2006 Nov; 63(11):1586-90. PubMed ID: 17101827
    [Abstract] [Full Text] [Related]

  • 4. Apolipoprotein E epsilon4 allele frequency in elderly depressed patients with and without cerebrovascular disease.
    Traykov L, Bayle AC, Latour F, Lenoir H, Seux ML, Hanon O, Péquignot R, Bert P, Moulin F, Cantegreil I, Wenisch E, Batouche F, Mehrabian S, Rotrou Jd, Rigaud AS.
    J Neurol Sci; 2007 Jun 15; 257(1-2):280-3. PubMed ID: 17337010
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.
    Hsiung GY, Sadovnick AD, Feldman H.
    CMAJ; 2004 Oct 12; 171(8):863-7. PubMed ID: 15477624
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
    McGuinness B, Carson R, Barrett SL, Craig D, Passmore AP.
    Neurosci Lett; 2010 Oct 08; 483(1):62-6. PubMed ID: 20678545
    [Abstract] [Full Text] [Related]

  • 10. Cognitive phenotypes in Alzheimer's disease and genetic variants in ACE and IDE.
    Vardy ER, Brown K, Stopford CL, Thompson JC, Richardson AM, Neary D, Kalsheker N, Morgan K, Mann DM, Snowden JS.
    Neurobiol Aging; 2012 Jul 08; 33(7):1486.e1-2. PubMed ID: 21232820
    [Abstract] [Full Text] [Related]

  • 11. Apolipoprotein E ε4 Modulates Cognitive Profiles, Hippocampal Volume, and Resting-State Functional Connectivity in Alzheimer's Disease.
    Wang X, Wang J, He Y, Li H, Yuan H, Evans A, Yu X, He Y, Wang H.
    J Alzheimers Dis; 2015 Jul 08; 45(3):781-95. PubMed ID: 25624419
    [Abstract] [Full Text] [Related]

  • 12. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ, Lee KS, Lee Y, Baek JH, Choi SH, Na DL, Seo SW, Oh BH, Hong CH.
    J Clin Psychiatry; 2012 Dec 08; 73(12):1555-62. PubMed ID: 23146133
    [Abstract] [Full Text] [Related]

  • 13. The APOE ε4 allele is associated with increased frontally mediated neurobehavioral symptoms in amnestic MCI.
    Mikos AE, Piryatinsky I, Tremont G, Malloy PF.
    Alzheimer Dis Assoc Disord; 2013 Dec 08; 27(2):109-15. PubMed ID: 22874659
    [Abstract] [Full Text] [Related]

  • 14. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
    Devanand DP, Pelton GH, Zamora D, Liu X, Tabert MH, Goodkind M, Scarmeas N, Braun I, Stern Y, Mayeux R.
    Arch Neurol; 2005 Jun 08; 62(6):975-80. PubMed ID: 15956169
    [Abstract] [Full Text] [Related]

  • 15. Most rapid cognitive decline in APOE epsilon4 negative Alzheimer's disease with early onset.
    van der Vlies AE, Koedam EL, Pijnenburg YA, Twisk JW, Scheltens P, van der Flier WM.
    Psychol Med; 2009 Nov 08; 39(11):1907-11. PubMed ID: 19335933
    [Abstract] [Full Text] [Related]

  • 16. APOE genotype in the diagnosis of Alzheimer's disease in patients with cognitive impairment.
    Sun X, Nicholas J, Walker A, Wagner MT, Bachman D.
    Am J Alzheimers Dis Other Demen; 2012 Aug 08; 27(5):315-20. PubMed ID: 22815080
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease.
    Bennett DA, Wilson RS, Schneider JA, Evans DA, Aggarwal NT, Arnold SE, Cochran EJ, Berry-Kravis E, Bienias JL.
    Neurology; 2003 Jan 28; 60(2):246-52. PubMed ID: 12552039
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.